Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Anthropic releases Claude Science, a product aimed at researchers, the pharma industry
SAN FRANCISCO — Anthropic, the artificial intelligence firm, on Tuesday announced the availability of Claude Science, an application that optimizes the company's large language model for use in scientific laboratories and, especially, within…
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
Company announcement No. 29 / 2026 Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, June 30, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Total number of shares and voting rights in Zealand Pharma as of June 30, 2026
Company announcement – No. 30 / 2026 Total number of shares and voting rights in Zealand Pharma as of June 30, 2026 Copenhagen, Denmark, June 30, 2026 – Zealand Pharma A/S (“Zealand Pharma” or 'the Company') (Nasdaq:…
Liminatus Pharma Amends InnocsAI Merger Deal, Sets July 2 Closing
Liminatus Pharma said Tuesday it amended its merger agreement with InnocsAI LLC to allow the deal to close before shareholder approval, with closing now expected July 2. InnocsAI equity holders will receive Liminatus common stock and non-voting…
Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development
We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Ascentage Pharma Group Internat (NASDAQ:AAPG) is one of the best biotech stocks on this list. TheFly reported on June 15 that Oppenheimer initiated coverage of…
Petrochemical Import Duty Waiver Extended To July 15 To Aid Plastics, Pharma, Textiles
New Delhi: The central government on Tuesday extended full customs duty exemption on critical petrochemical products, given in view of the conflict in West Asia, till July 15. A Finance Ministry release said that the Government had earlier provided…
Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Let Go of 10,000 Shares?
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN +2.02%), reported the sale of 10,000 shares of common stock in an open-market transaction on June 22, 2026, according to a SEC Form 4 filing. MetricValueShares sold…
Mankind Pharma partners Denovo Sciences for AI-led drug discovery
Mankind Pharma Ltd on Wednesday announced a strategic collaboration with Denovo Sciences to launch an AI-led drug discovery programme. The partnership marks an important step in the company's focus on innovation-driven and technology-enabled…
Chugai Pharma Taiwan Wins Asia Responsible Enterprise Awards for Fifth Consecutive Year
Chugai Pharma Taiwan (CPT) has once again achieved a landmark milestone in sustainability, earning recognition at one of Asia's most prestigious sustainability honors — the Asia Responsible Enterprise Awards (AREA). This year's awards…
What the Future of Beauty Holds, According to Five Top Scientists
While chemistry dominated beauty for 100 years, its future may lie in biology. Personalization, holistic approaches and consumer savviness are also expected to define the landscape. “Engineering ingredients for specific biological outcomes…
Apollo's top economist warns of a painful market repricing as return on AI investment slows
Uneven returns on AI investment could be a wakeup call for the red-hot stock market, a top economist says. US equities are roaring, with unrelenting tech bullishness putting the the Nasdaq 100 on track for its best quarter in years. Yet, Torsten…
Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play (NASDAQ:ABVX)
ABIVAX Société Anonyme surged >35% on positive Phase 3 data for obefazimod in ulcerative colitis, reinforcing its differentiated, multi-pathway mechanism and best-in-class profile. Recent safety data alleviated cancer concerns…
Reimagining sovereign AI for India's strategic future
The United States government recently directed American Artificial Intelligence (AI) behemoth Anthropic to suspend access to its most advanced Fable 5 and Mythos 5 models for foreign nationals on national security grounds. A U.S. Presidential order…
Idorsia appoints Roland Wandeler as Chief Executive Officer
Ad hoc announcement pursuant to Art. 53 LR Idorsia appoints Roland Wandeler as CEO – effective October 1, 2026 – an experienced biopharmaceutical executive combining scientific expertise with business acumen to translate innovation…
Eli Lilly just placed a $40 million bet on the next injectable boom
Eli Lilly just wrote a $40 million check to cure baldness. The pharma giant behind Zepbound and Mounjaro—which made the injectable culturally normal for millions of Americans—led a $100 million stock offering in Absci, a generative AI…
Receive a Daily briefing on Pharma Industry News
Get Started